Antibiotics-Induced Obesity: A Mitochondrial Perspective

Area of Science:

• Microbiology
• Metabolic Health
• Genetics

Background:

• Antibiotics are crucial for treating infections but their overuse has led to antibiotic resistance and gut microbiome alterations.
• Unregulated antibiotic use is linked to metabolic dysfunction and obesity in both children and adults.
• Obesity pathogenesis involves complex genetic, epigenetic, and environmental factors, including cellular and organ-level alterations.

Purpose of the Study:

• To review the intricate relationship between antibiotic usage, obesity, and mitochondrial dysfunction.
• To explore the molecular mechanisms, genetic predispositions, and environmental factors involved.
• To identify potential clinical applications for managing antibiotic use and its metabolic consequences.

Main Methods:

• Literature review focusing on the interplay between antibiotics, obesity, and mitochondrial dysfunction.
• Analysis of current research on the impact of antibiotics on gut microbiome and host metabolism.
• Exploration of the role of mitochondrial dysfunction in obesity and its connection to antibiotic exposure.

Main Results:

• Antibiotic exposure can alter gut microbiota composition, impacting host metabolism and energy homeostasis.
• Mitochondrial dysfunction is increasingly recognized as a key factor in obesity development.
• The review highlights a potential link between antibiotic-induced gut dysbiosis, metabolic changes, and mitochondrial impairment.

Conclusions:

• Antibiotic use is a significant environmental factor influencing obesity risk through microbiome and metabolic pathways.
• Mitochondrial dysfunction may be a critical mediator in the development of antibiotic-associated obesity.
• Understanding these connections offers novel avenues for therapeutic interventions targeting antibiotic use and metabolic health.